• About
  • Contact
  • Resources
  • Book Nook
Donate
  • Featured
  • Commentary
  • Science & News
  • Mainstream
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Michael Lerner’s Blog
    • Guest Authors
MenuClose
  • Featured
  • Commentary
  • Science & News
  • Mainstream Solutions
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative Therapies
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Guest Authors
    • Michael Lerner’s Blog
  • About
  • Contact
  • Resources
  • Donate

Cancer


Moderna’s COVID-19 Vaccine May Be More Effective for Cancer Patients

Moderna’s COVID-19 Vaccine May Be More Effective for Cancer Patients

by Covid Strategies | Jun 4, 2022 | Vaccines

By Victoria Forster, PhD; originally published April 29, 2022 One theory is that the Moderna vaccine may be more effective because it contains more mRNA. Source: Getty Images Growing evidence suggests that patients with cancer have better responses to the Moderna...

read more
COVID-19 Vaccines Most Effective in Patients With Myeloma and Gastrointestinal, Lung Cancers

COVID-19 Vaccines Most Effective in Patients With Myeloma and Gastrointestinal, Lung Cancers

by Covid Strategies | Jun 2, 2022 | Vaccines

By Jonathan Goodman, MPhil COVID-19 vaccines confer varying levels of protection in patients with cancer, according to research published in The Lancet Oncology. Researchers found that overall vaccine effectiveness was lower in patients with cancer than in the...

read more
Protecting the Immunocompromised From COVID-19: Practical Information for Physicians

Protecting the Immunocompromised From COVID-19: Practical Information for Physicians

by Covid Strategies | Apr 6, 2022 | Science & News

By Chase Doyle COVID-19 may have caught the world off guard in 2020, but in the 2 years since the pandemic began, several effective monoclonal antibodies and antiviral drugs have emerged to protect the most vulnerable patients. The ASCO Post spoke with Gunjan L. Shah,...

read more
Third COVID-19 Vaccine Dose May Improve Immune Response in Patients With Lymphoma

Third COVID-19 Vaccine Dose May Improve Immune Response in Patients With Lymphoma

by Covid Strategies | Mar 30, 2022 | Science & News, Vaccines

New research has found that the weakened immune systems of patients with lymphoma may improve after they receive a third COVID-19 vaccination. Patients with lymphoma have defects in their immune system that restrict its response to vaccination; despite this, a study...

read more
Study Finds Black Patients With Cancer Diagnosed With COVID-19 Have Worse Outcomes Than White Patients

Study Finds Black Patients With Cancer Diagnosed With COVID-19 Have Worse Outcomes Than White Patients

by Covid Strategies | Mar 30, 2022 | Science & News

Black patients with cancer experienced significantly worse outcomes after a COVID-19 diagnosis than non-Hispanic White patients, according to findings published by Fu et al in JAMA Network Open. Investigators from the COVID-19 and Cancer...

read more
Polish Preprint: mRNA COVID Vaccine Caused In Vitro Brain Cell Changes “Similar to Those in Cancer Cells”

Polish Preprint: mRNA COVID Vaccine Caused In Vitro Brain Cell Changes “Similar to Those in Cancer Cells”

by Covid Strategies | Mar 25, 2022 | Science & News, Vaccines

A Polish research team used a spectroscopy technique called Raman imaging to conduct a preclinical study of the effect of COVID-19 mRNA (Pfizer/BioNT) vaccine on in vitro glial cells of the brain. Lodz University Research Team The team members include Halina...

read more
Risk of COVID-19 Infection and Complications Among Survivors of Childhood, Adolescent, and Young Adult Cancers

Risk of COVID-19 Infection and Complications Among Survivors of Childhood, Adolescent, and Young Adult Cancers

by Covid Strategies | Mar 9, 2022 | Science & News

By Matthew Stenger In a Canadian population-based study reported in the Journal of Clinical Oncology, Gupta et al found that survivors of childhood, adolescent, and young adult cancers were not at a greater risk of COVID-19 infection or severe complications of...

read more
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

by Covid Strategies | Mar 8, 2022 | Featured, Vaccines

By Ajay K. Nooka, MD, et al. ABSTRACT PURPOSE Vaccine-induced neutralizing antibodies (nAbs) play a critical role in protection from SARS CoV-2. Patients with B-cell malignancies including myeloma are at increased risk of COVID-19–related mortality and exhibit...

read more
T-Cell Responses May Help Predict Protection Against SARS–CoV-2 Infection in Individuals With and Without Cancer

T-Cell Responses May Help Predict Protection Against SARS–CoV-2 Infection in Individuals With and Without Cancer

by Covid Strategies | Feb 23, 2022 | Science & News

T-cell responses directed against the receptor-binding domain of the SARS–CoV-2 spike protein were associated with protection from SARS–CoV-2 infection in vaccinated individuals with or without cancer, with lower T-cell responses observed in patients with blood...

read more
Study Finds Patients With Lung Cancer Demonstrated Psychological Resilience in the Face of the COVID-19 Pandemic

Study Finds Patients With Lung Cancer Demonstrated Psychological Resilience in the Face of the COVID-19 Pandemic

by Covid Strategies | Feb 11, 2022 | Science & News

Far from being hobbled by fears of COVID-19, patients with lung cancer actually showed less depression and anxiety during the pandemic than their healthy peers, according to results from a new study by Arrato et al published in JNCCN–Journal of the National...

read more
Adverse Event Rates After Two Doses of mRNA COVID-19 Vaccine in Patients With vs Without Cancer

Adverse Event Rates After Two Doses of mRNA COVID-19 Vaccine in Patients With vs Without Cancer

by Covid Strategies | Feb 9, 2022 | Science & News, Vaccines

New research published by Shulman et al in JNCCN—Journal of the National Comprehensive Cancer Network confirmed that mRNA vaccines for COVID-19 are just as safe for people with cancer as they are for cancer-free individuals. Researchers from a single institution...

read more
First patients of pioneering CAR T-cell therapy ‘cured of cancer’

First patients of pioneering CAR T-cell therapy ‘cured of cancer’

by Covid Strategies | Feb 2, 2022 | Science & News

Cancer-killing cells still present 10 years on, with results suggesting therapy is a cure for certain blood cancers By Linda Geddes Two of the first human patients to be treated with a revolutionary therapy that engineers immune cells to target specific types of...

read more
Immunogenicity of COVID-19 BNT162b2 mRNA Vaccine Booster in Patients With Cancer Receiving Active Treatment

Immunogenicity of COVID-19 BNT162b2 mRNA Vaccine Booster in Patients With Cancer Receiving Active Treatment

by Covid Strategies | Jan 10, 2022 | Mainstream Prevention, Mainstream Solutions, Vaccines

By Matthew Stenger In an Israeli single-institution study reported in The Lancet Oncology, Ligumsky et al found that a booster dose of the SARS–CoV-2 Pfizer-BioNTech BNT162b2 mRNA vaccine given in August or September 2021 was immunogenic in patients receiving...

read more
Fully Vaxxed Cancer Patients Face Sky-High Risk for Hospitalization & High Risk for Death

Fully Vaxxed Cancer Patients Face Sky-High Risk for Hospitalization & High Risk for Death

by Covid Strategies | Dec 25, 2021 | Featured, Vaccines

Recently, oncologists from a network of oncology center-based care and research centers including the Dana-Farber Cancer Institute and Vanderbilt University, and others report that people with cancer who are fully vaccinated against COVID-19 still face...

read more
COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer

COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer

by Covid Strategies | Dec 24, 2021 | Featured, Science & News

By A.L.Schmidt Highlights • Patients with cancer who develop breakthrough COVID-19 following full vaccination remain susceptible to severe outcomes. •Hematologic malignancies are over-represented among vaccinated patients with cancer who develop breakthrough COVID-19....

read more
Page 1 of 3123»

Address:

Commonweal P.O Box 316 | Bolinas, CA 94924

Latest Covid news in your inbox!

Success!

Subscribe

Search Articles

©2021 CovidStrategies/Commonweal | Site maintained by Mercury Multimedia

Privacy Policy | Home